The multifaceted roles of nucleophagy in cancer development and therapy

Lili Zhao1, Wenxi Li2,3, Xu Luo4

  • 1Key Laboratory of Neuroregeneration of Jiangsu, Ministry of Education, Nantong University, Nantong, Jiangsu, China.

Cell Biology International
|November 21, 2020
PubMed

Insights

Nucleophagy, a type of cellular recycling, has a dual role in cancer. While it can prevent cancer by clearing damaged DNA, it may also promote tumor growth and spread.

Area of Science:

  • Cell Biology
  • Oncology
  • Molecular Biology

Background:

  • Autophagy is a fundamental cellular process for maintaining homeostasis by degrading and recycling cellular components.
  • Nucleophagy, or nuclear autophagy, is a specialized form of autophagy targeting nuclear material like DNA and nuclear lamina.
  • The role of nucleophagy in cancer is complex, acting as both a tumor suppressor and a facilitator of tumor progression.

Purpose of the Study:

  • To review the multifaceted role of nucleophagy in cancer development.
  • To explore potential therapeutic strategies targeting nucleophagy in cancer treatment.
  • To highlight areas for future research in the oncological context of nucleophagy.

Main Methods:

  • Literature review of existing research on autophagy and nucleophagy.
  • Analysis of the dual role of nucleophagy in cancer initiation and progression.
  • Discussion of potential intervention points for cancer therapy.

Main Results:

  • Nucleophagy's clearance of damaged DNA and nuclear structures is vital for preventing initial tumor formation.
  • In established tumors, nucleophagy can support cancer cell survival and metastasis, particularly in nutrient-poor environments.
  • Targeting nuclear components, such as the nuclear lamina, during nucleophagy presents a potential therapeutic avenue.

Conclusions:

  • Nucleophagy's intricate involvement in cancer necessitates careful consideration for therapeutic manipulation.
  • Further investigation into nucleophagy's molecular pathways and links to tumor suppressors is crucial for developing effective cancer treatments.
  • Targeting nucleophagy offers a promising, yet complex, strategy for future oncological interventions.

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K